Search results
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 9 hours agodropped nearly 30% in premarket trading Monday after the company said its experimental...
Texas Company's Mission to Cure Macular Degeneration Blindness
The Joplin Globe· 6 days agoTwenty Million people in America (12% of the population over 40) have Macular Degeneration and Two...
EyePoint reports mixed results in diabetic retinopathy trial By Investing.com
Investing.com· 4 hours agoEyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) announced interim results from its Phase 2...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga via Yahoo Finance· 7 hours agoOn Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2...
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 9 hours agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 4 days agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 5 days agoThe paper-based KeepSight Journal from the International Macular and Retinal Foundation, Genentech's...
Retinal hemorrhage: Causes, risk factors, and symptoms
Medical News Today· 6 days agoWhat is a retinal hemorrhage? Read on to learn more about bleeding in the eye, including different...
...Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry...
Benzinga· 5 days agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the
Scientists find potential treatment target for leading cause of blindness
Investing.com· 5 days agoNew Delhi, May 2 (IANS) US scientists have found answers to why treatment for neovascular...